IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Avidity Biosciences Inc (RNA)

CUSIP: 05370A108 | NYSE | Healthcare · Biotechnology | Micro Cap | 646 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ARTW Investments, LP4,686,1103.1%Newly reportedOct 27, 202511,372,829 sh (Sep 30, 2025)
13D/ARTW Investments, LP4,686,110
3.1% of class · Oct 27, 2025Newly reported
11,372,829 sh (Sep 30, 2025)

Institutional Holders — Q1 2026

Corsicana & Co.8,000
0.1% of portfolio›$236.2K
Vanguard Group Inc0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Corsicana & Co.
8,000$236.2K0.1%CoreLowCorsicana, TX2026-05-13
Vanguard Group Inc
0$00.0%N/AN/AValley Forge, PA2026-05-14